Use of short-acting beta agonists in the treatment of asthma across five European countries

Drug Ther Bull. 2022 Feb;60(2):21-23. doi: 10.1136/dtb.2021.000067. Epub 2022 Jan 13.

Abstract

Commentary on: Janson C, Menzies-Gow A, Nan C, et al SABINA: an overview of short-acting β2-agonist use in asthma in European countries. Adv Ther 2020;37:1124-35.Series co-ordinator: Dr Teck Khong, DTB Associate Editor Clinical Pharmacology, St George's, University of London, UK.

Keywords: asthma; therapeutics.

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Agonists / therapeutic use
  • Asthma* / drug therapy
  • Europe
  • Humans

Substances

  • Adrenergic beta-Agonists